Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
5.25
-0.29 (-5.15%)
Mar 9, 2026, 1:02 PM EDT - Market open
Evolus Employees
Evolus had 334 employees as of December 31, 2025. The number of employees increased by 2 or 0.60% compared to the previous year.
Employees
334
Change (1Y)
2
Growth (1Y)
0.60%
Revenue / Employee
$889,749
Profits / Employee
-$154,614
Market Cap
341.24M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Canopy Growth | 960 |
| Emergent BioSolutions | 900 |
| Organogenesis Holdings | 854 |
| Kamada | 420 |
| Lifecore Biomedical | 406 |
| Ironwood Pharmaceuticals | 253 |
| Akebia Therapeutics | 194 |
| Aquestive Therapeutics | 142 |
EOLS News
- 5 days ago - Evolus, Inc. (EOLS) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Evolus Reports Fourth Quarter and Full-Year 2025 Financial Results; Delivers Sixth Consecutive Year of Double-Digit Growth and Expects Sustainable Profitability1 Beginning in 2026 - Business Wire
- 12 days ago - Evolus to Participate in The Leerink Partners Global Healthcare Conference - Business Wire
- 20 days ago - Evolus to Report Fourth Quarter and Full-Year 2025 Financial Results on March 3, 2026 - Business Wire
- 23 days ago - Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 2 months ago - Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2025 Net Revenue - Business Wire
- 3 months ago - AMG Frontier Small Cap Growth Fund: Q3 Sees Strong Outperformance Across Semiconductor Holdings - Seeking Alpha
- 4 months ago - Evolus, Inc. (EOLS) Q3 2025 Earnings Call Transcript - Seeking Alpha